IDEXX LABORATORIES INC (IX1.DE) Stock Price, Forecast & Analysis

Europe • Frankfurt Stock Exchange • FRA:IX1 • US45168D1046

566.6 EUR
-1.4 (-0.25%)
Last: Feb 2, 2026, 07:00 PM

IX1.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap45.24B
Revenue(TTM)4.17B
Net Income(TTM)1.03B
Shares79.85M
Float79.30M
52 Week High663.2
52 Week Low349.2
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)10.65
PE53.2
Fwd PE45.36
Earnings (Next)02-02
IPO1991-06-21
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
IX1.DE short term performance overview.The bars show the price performance of IX1.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20

IX1.DE long term performance overview.The bars show the price performance of IX1.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40

The current stock price of IX1.DE is 566.6 EUR. In the past month the price decreased by -4.03%. In the past year, price increased by 40.81%.

IDEXX LABORATORIES INC / IX1 Daily stock chart

IX1.DE Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to IX1.DE. When comparing the yearly performance of all stocks, IX1.DE is one of the better performing stocks in the market, outperforming 91.97% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

IX1.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to IX1.DE. IX1.DE scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IX1.DE Financial Highlights

Over the last trailing twelve months IX1.DE reported a non-GAAP Earnings per Share(EPS) of 10.65. The EPS increased by 15.16% compared to the year before.


Industry RankSector Rank
PM (TTM) 24.65%
ROA 30.34%
ROE 65.81%
Debt/Equity 0.53
Chartmill High Growth Momentum
EPS Q2Q%21.43%
Sales Q2Q%13.29%
EPS 1Y (TTM)15.16%
Revenue 1Y (TTM)8.39%

IX1.DE Forecast & Estimates

22 analysts have analysed IX1.DE and the average price target is 663.13 EUR. This implies a price increase of 17.04% is expected in the next year compared to the current price of 566.6.

For the next year, analysts expect an EPS growth of 16.89% and a revenue growth 10.46% for IX1.DE


Analysts
Analysts80.91
Price Target663.13 (17.04%)
EPS Next Y16.89%
Revenue Next Year10.46%

IX1.DE Ownership

Ownership
Inst Owners94.94%
Ins Owners0.21%
Short Float %N/A
Short RatioN/A

IX1.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
2M6.DE MEDTRONIC PLC 18.28 111.57B
1MDT.MI MEDTRONIC PLC 17.75 108.30B
SHL.DE SIEMENS HEALTHINEERS AG 17.82 48.04B
1PHIA.MI KONINKLIJKE PHILIPS NV 16.73 23.84B
PHIA.AS KONINKLIJKE PHILIPS NV 16.53 23.55B
PHI1.DE KONINKLIJKE PHILIPS NV 16.46 23.46B
BIM.PA BIOMERIEUX 25.04 11.44B
DIA.MI DIASORIN SPA 21.84 4.04B
OBCK.DE OTTOBOCK SE & CO KGAA 130.11 3.91B
1AFX.MI CARL ZEISS MEDITEC AG - BR 17.45 2.51B
AFX.DE CARL ZEISS MEDITEC AG - BR 17.3 2.49B
DRW3.DE DRAEGERWERK AG - PREF 13.64 1.65B

Related stock screener links

About IX1.DE

Company Profile

IX1 logo image IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

Company Info

IDEXX LABORATORIES INC

One Idexx Drive

Westbrook MAINE US

Employees: 11000

IX1 Company Website

IX1 Investor Relations

Phone: 12075560300

IDEXX LABORATORIES INC / IX1.DE FAQ

What does IDEXX LABORATORIES INC do?

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.


What is the stock price of IDEXX LABORATORIES INC today?

The current stock price of IX1.DE is 566.6 EUR. The price decreased by -0.25% in the last trading session.


Does IX1 stock pay dividends?

IX1.DE does not pay a dividend.


What is the ChartMill technical and fundamental rating of IX1 stock?

IX1.DE has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


What is the analyst forecast for IX1.DE stock?

22 analysts have analysed IX1.DE and the average price target is 663.13 EUR. This implies a price increase of 17.04% is expected in the next year compared to the current price of 566.6.


Can you provide the market cap for IDEXX LABORATORIES INC?

IDEXX LABORATORIES INC (IX1.DE) has a market capitalization of 45.24B EUR. This makes IX1.DE a Large Cap stock.


What is the next earnings date for IX1 stock?

IDEXX LABORATORIES INC (IX1.DE) will report earnings on 2026-02-02, before the market open.